Miglustat

Formula: C₁₀H₁₂NO₄

Molecular weight: 219.28 g/mol

Therapeutic area: Glucosylceramide synthase inhibitor, Treatment of Gaucher Disease

Monographs:

Regulatory filings: EU approved, DMF under review with Health Canada and FDA

Manufactured in: US

* Monographs are available on request
† Other filings are available on request